Fighting Disease

As humans have evolved so has our capacity to fend off and prevent diseases that threaten our wellbeing. From existing diseases like cancer—which stands to affect nearly 40% of people at some point in their lifetimes—to emerging viruses like COVID-19, public companies remain tireless in their pursuit for a cure. This theme includes disease-fighting public companies like Eli Lilly, Exelixis, Moderna, and Pfizer.

36 stocks • 4 ETFs

Stocks

DVAX
Dynavax Technologies

DVAX

GILD

ETFs

Note: This Public Theme is based on data from one or more third-party data providers. This Theme is provided for informational purposes only by Public Holdings, Inc., and is not investment advice or an investment recommendation. You should not buy or sell anything included in this Public Theme without first determining it is appropriate for your portfolio or investment strategy. Investors should consider the investment objectives and unique risk profile of an Exchange Traded Product (“ETP”) and read the ETP’s prospectus carefully before investing.
Buy stocks with any amount of money.